421 related articles for article (PubMed ID: 20133198)
1. Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.
Wells TN; Burrows JN; Baird JK
Trends Parasitol; 2010 Mar; 26(3):145-51. PubMed ID: 20133198
[TBL] [Abstract][Full Text] [Related]
2. Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
Betuela I; Robinson LJ; Hetzel MW; Laman M; Siba PM; Bassat Q; Mueller I
P N G Med J; 2014; 57(1-4):68-74. PubMed ID: 26930890
[TBL] [Abstract][Full Text] [Related]
3. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
[TBL] [Abstract][Full Text] [Related]
4. [New use of primaquine for malaria].
Oliver M; Simon F; de Monbrison F; Beavogui AH; Pradines B; Ragot C; Moalic JL; Rapp C; Picot S
Med Mal Infect; 2008 Apr; 38(4):169-79. PubMed ID: 18395381
[TBL] [Abstract][Full Text] [Related]
5. Observations on early and late post-sporozoite tissue stages in primate malaria. II. The hypnozoite of Plasmodium cynomolgi bastianellii from 3 to 105 days after infection, and detection of 36- to 40-hour pre-erythrocytic forms.
Krotoski WA; Bray RS; Garnham PC; Gwadz RW; Killick-Kendrick R; Draper CC; Targett GA; Krotoski DM; Guy MW; Koontz LC; Cogswell FB
Am J Trop Med Hyg; 1982 Mar; 31(2):211-25. PubMed ID: 7041663
[TBL] [Abstract][Full Text] [Related]
6. Dormancy in mammalian malaria.
Markus MB
Trends Parasitol; 2012 Feb; 28(2):39-45. PubMed ID: 22118814
[TBL] [Abstract][Full Text] [Related]
7. Problems in the therapy for imported malaria in the United States.
Singh K; Wester WC; Trenholme GM
Arch Intern Med; 2003 Sep; 163(17):2027-30. PubMed ID: 14504115
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of artesunate in Plasmodium vivax malaria in Thailand.
Hamedi Y; Safa O; Zare S; Tan-ariya P; Kojima S; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):570-4. PubMed ID: 15689068
[TBL] [Abstract][Full Text] [Related]
9. [Epidemiological and therapeutic aspects of plasmodial infection from Plasmodium vivax].
Nicolas X; Granier H; Martin J; Klotz F
Med Trop (Mars); 2000; 60(4):402-8. PubMed ID: 11436600
[TBL] [Abstract][Full Text] [Related]
10. A plant-derived morphinan as a novel lead compound active against malaria liver stages.
Carraz M; Jossang A; Franetich JF; Siau A; Ciceron L; Hannoun L; Sauerwein R; Frappier F; Rasoanaivo P; Snounou G; Mazier D
PLoS Med; 2006 Dec; 3(12):e513. PubMed ID: 17194195
[TBL] [Abstract][Full Text] [Related]
11. Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission.
White MT; Karl S; Battle KE; Hay SI; Mueller I; Ghani AC
Elife; 2014 Nov; 3():. PubMed ID: 25406065
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary edema due to Plasmodium vivax malaria in an American missionary.
Illamperuma C; Allen BL
Infection; 2007 Oct; 35(5):374-6. PubMed ID: 17721740
[TBL] [Abstract][Full Text] [Related]
13. The hypnozoite and malarial relapse.
Krotoski WA
Prog Clin Parasitol; 1989; 1():1-19. PubMed ID: 2491691
[TBL] [Abstract][Full Text] [Related]
14. Primaquine as prophylaxis for malaria for nonimmune travelers: A comparison with mefloquine and doxycycline.
Schwartz E; Regev-Yochay G
Clin Infect Dis; 1999 Dec; 29(6):1502-6. PubMed ID: 10585803
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium vivax - How hidden reservoirs hinder global malaria elimination.
Angrisano F; Robinson LJ
Parasitol Int; 2022 Apr; 87():102526. PubMed ID: 34896312
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of a gradual dormancy concept in malaria.
Richter J; Franken G; Holtfreter MC; Walter S; Labisch A; Mehlhorn H
Parasitol Res; 2016 Jun; 115(6):2139-48. PubMed ID: 27079460
[TBL] [Abstract][Full Text] [Related]
17.
Schäfer C; Zanghi G; Vaughan AM; Kappe SHI
Annu Rev Microbiol; 2021 Oct; 75():87-106. PubMed ID: 34196569
[No Abstract] [Full Text] [Related]
18. [Drug resistance of Plasmodium falciparum and Plasmodium vivax strains in Cambodia (Cardamone Massif). Morphological characteristics of Plasmodium vivax].
Lapierre J; Coquelin B; Galal AA; Dupouy-Camet J; Faurant C; Tourte-Schaefer C; Ancelle T; Heyer F
Med Trop (Mars); 1984; 44(4):339-49. PubMed ID: 6394948
[TBL] [Abstract][Full Text] [Related]
19. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
[TBL] [Abstract][Full Text] [Related]
20. Drug resistance in malaria: three cases and a review.
Isaac-Renton JL; Koon AL; Chan RM; Chow AW; Sacks SL
Can Med Assoc J; 1983 Sep; 129(5):454-7. PubMed ID: 6349767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
